GRANIONS DE MAGNESIUM 3,82 mg/2 ml S buv 30Amp/2ml

Oral solution.
Ampoule with two self-breaking tips of 2 mL. Box of 30.

For one ampoule of 2 mL:

Magnesium chloride: 32,00 mg
Corresponding amount of magnesium: 3,82 mg

Used as a terrain modifier, in particular during states of neurovegetative dystonia and states grouped under the term spasmophilia.

Dosage

RESERVED FOR ADULTS.

2 to 3 ampoules per day.

Method of administration:

It is advised to take the contents of the ampoules diluted in a glass of water, outside meals.

Hypersensitivity to the active substance or to any of the excipients listed in section Composition

Treatment with this trace mineral element does not replace any specific treatment that may be needed.

The data available to date do not suggest the existence of clinically significant interactions.

No adverse effects are expected with these doses of magnesium during pregnancy and breastfeeding.

To date, no adverse effects have been reported.

Reporting of suspected adverse reactions

Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system: National Agency for the Safety of Medicines and Health Products (ANSM) and the network of Regional Pharmacovigilance Centres - Website: https://signalement.social-sante.gouv.fr/.

No cases of overdose have been reported; however, use of excessive doses may lead to nausea, vomiting, loss of muscle tone, hypotension and arrhythmias, particularly in renally impaired patients, who are the most vulnerable subjects.

Pharmacotherapeutic class: OLIGOTHERAPY (V: various)

Trace mineral element.

2 years.

Store at a temperature below 25 °C.

No special requirements.